Stocks
Castle Biosciences, Inc.

Castle Biosciences, Inc.CSTL

NASDAQHealthcareBiotechnology$32.33+0.95%

Price as of · delayed, not real-time

Specializing in diagnostic tests for skin cancer and other dermatological conditions, the company provides decision-making tools for physicians and patients. Its focus on precision medicine and growing portfolio of tests make it a key player in the diagnostics space.

Market Cap: $759.9M52W Range: $17.72-$44.28

Congressional Interest in Castle Biosciences, Inc. (CSTL)

2 members of Congress have disclosed 3 trades in Castle Biosciences, Inc. (CSTL), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.

Total Disclosures
3
Unique Politicians
2
Buys
2
Sells
1

Who in Congress Is Trading CSTL?

2022-03-15$1K-$15K
Stock
2020-12-23$1K-$15K
Stock
2020-12-21$1K-$15K
Stock